Davis G C, Bunney W E
Adv Biochem Psychopharmacol. 1980;22:455-63.
Suggestive evidence exists linking endorphins to the schizophrenic syndrome; narcotic antagonists appear to slightly attenuate some symptoms, attentional performance is improved and CSF opiate-binding substances are reported to be elevated in a sub-group of patients. Many fewer affectively ill patients have been studied and little evidence has accumulated suggesting a relationship between symptoms of affective illness and endorphins although CSF endorphins appear elevated in some manic-depressive patients and "pain patients" with depression have higher CSF endorphins than pain patients without depression. Catatonic symptoms as well as other psychomotor functions remain promising areas for study. Opioid effects on manic symptoms have been reported by only a few research groups and would benefit from study with longer-acting antagonists administered daily.
有提示性证据表明内啡肽与精神分裂症综合征有关;麻醉拮抗剂似乎能轻微减轻某些症状,注意力表现得到改善,据报道,在一部分患者中脑脊液阿片类结合物质升高。对情感性疾病患者的研究较少,几乎没有证据表明情感性疾病症状与内啡肽之间存在关联,尽管在一些躁狂抑郁症患者中脑脊液内啡肽似乎升高,并且“疼痛伴抑郁患者”的脑脊液内啡肽水平高于无抑郁的疼痛患者。紧张症症状以及其他精神运动功能仍是有前景的研究领域。只有少数研究小组报道了阿片类药物对躁狂症状的影响,使用长效拮抗剂进行每日研究将有助于这方面的研究。